Notably, treatment with NGF restored NRN1 levels in these tissues, suggesting that the neurotrophic deficit in diabetes contributes to suppressed NRN1 signaling and that upstream neurotrophins may regulate NRN1 expression. This evidence concerns the gene NRN1 and diabetes mellitus.